ODDB.org: Open Drug Database

Home - 55674 - 01 - 005

Caverject DC 10, Pulver und Lösungsmittel zur Herstellung einer Injektionslösung in einer Fertigspritze - 2 Spritze(n)

Swissmedic Key	55674005	Registration Holder	Pfizer AG
Name	Caverject DC 10, Pulver und Lösungsmittel zur Herstellung einer Injektionslösung in einer Fertigspritze	Date of registration	06.03.2002
		Introduction of Sequence	06.03.2002
ATC-Classification	Alprostadil (G04BE01)	Revision date	05.03.2007
WHO	WHO-DDD	Valid until
Index Therapeuticus (BSV)	02.04.50.	Show package size	2 Spritze(n)
Index Therapeuticus (Swissmedic)	05.99.	Description
Swissmedic categorie.	A
SL Eintrag	Yes	Indication
Information for professionals	IP	Consumer information	CI
Ex-factory-Price	16.39	Limitation	Yes
Limitation text

Deductible	10 %	Consumer price	34.25
Feedback	FB	Daily cost
GTIN	7680556740051	Medication Code	Synthetika
Pharmacode	2497111	Disponibility	●

Composition

Praeparatio cryodesiccata: alprostadilum 10 µg, alfadexum, lactosum, natrii citras anhydricus corresp. natrium 6.28 µg, acidum hydrochloridum aut natrii hydroxidum, aqua ad iniectabile, pro vitro. Solvens: alcohol benzylicus 4.45 mg, aqua ad iniectabile, ad solutionem pro 0.5 ml.

Packungsbestandteile

Label

Praeparatio cryodesiccata:

Galenic Form

Injection preparation

Excipiens

Active Agent	Dose
Alprostadil	10 µg

BAG: Active Agent	Dose
Alprostadil	0.01 mg

Inactive agents
Alfadexum
Lactosum
Natrii Citras Dihydricus

Label

Solvens

Galenic Form

Injection preparation

Excipiens

BAG: Active Agent	Dose
Alprostadil	0.01 mg

Inactive agents	Dose	additional_information
Alcohol Benzylicus	4.45mg / 0.5ml	conserv.

Source

Data was imported : 05.08.2022 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :

2025	©ywesee GmbH